Literature DB >> 3319299

Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.

P L Tazzari1, M Gobbi, A Dinota, A Bontadini, G Grassi, C Cerato, M Cavo, S Pileri, F Caligaris-Cappio, S Tura.   

Abstract

Three monoclonal antibodies (MoAb), named 8A, 8F6 and 62B1, reacting with plasma cell-associated antigens, were characterized. 8A was found to be positive throughout the B cell lineage maturation steps from the immature B-committed CD10+ cell to the plasma cells. 8F6 and 62B1 reactivity is restricted to more mature cells and related lymphoid malignancies. In particular 62B1 appears to be limited to hairy cells and plasma cells. The results show that it is possible to obtain reagents reacting with plasma cells by immunizing mice with cells derived from human multiple myelomas. Furthermore, the obtained results suggest that it is possible to elicit antibodies against antigens which are present throughout all the differentiation steps of the B cell lineage. These new MoAb could help in elucidating the phenotype of the plasma cells and the relationships of multiple myelomas with other B cell proliferative disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319299      PMCID: PMC1542220     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Terminal B cell development as seen in different human myelomas and related disorders.

Authors:  G F Burns; C P Worman; B E Roberts; C G Raper; C R Barker; J C Cawley
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

2.  The monoclonal nature of lymphocytes in multiple myeloma. Effects of therapy.

Authors:  N I Abdou; N L Abdou
Journal:  Ann Intern Med       Date:  1975-07       Impact factor: 25.391

3.  Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development.

Authors:  J Halper; S M Fu; C Y Wang; R Winchester; H G Kunkel
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

4.  Studies on the origin of the precursor cells in multiple myeloma, Waldenström's macroglobulinaemia and benign monoclonal gammopathy. I. Cytoplasmic isotype and idiotype distribution in peripheral blood and bone marrow.

Authors:  B Van Camp; P Reynaert; L Broodtaerts
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

5.  A monoclonal antibody reactive with a subset of human plasma cells.

Authors:  N J Gonchoroff; J A Katzmann; J P Garton; G J Ruiz-Argüelles; C R Eilers; P R Greipp; R A Kyle
Journal:  Br J Haematol       Date:  1986-04       Impact factor: 6.998

6.  Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

7.  Plasma cell antigens in human multiple myeloma.

Authors:  M R Mackenzie; T G Paglieroni
Journal:  J Lab Clin Med       Date:  1977-05

8.  Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens.

Authors:  R W Schroff; K A Foon; R J Billing; J L Fahey
Journal:  Blood       Date:  1982-02       Impact factor: 22.113

9.  Stages of B cell differentiation in human lymphoid tissue.

Authors:  A K Bhan; L M Nadler; P Stashenko; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

10.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  12 in total

1.  Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.

Authors:  R Leo; M Boeker; D Peest; R Hein; R Bartl; J E Gessner; J Selbach; G Wacker; H Deicher
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

2.  CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.

Authors:  M Zandecki; T Facon; F Bernardi; V Izydorczyk; L Dupond; M François; R Reade; T Iaru; F Bauters; A Cosson
Journal:  J Clin Pathol       Date:  1995-06       Impact factor: 3.411

3.  The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein.

Authors:  A H Banham; H Turley; K Pulford; K Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

4.  An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens.

Authors:  N Jackson; N R Ling; J Ball; E Bromidge; P D Nathan; I M Franklin
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

5.  In situ immunocytochemical staining of cell colonies growing in plasma clot.

Authors:  A Bontadini; M Gobbi; A Dinota; P L Tazzari; M T Rivano; S Pileri
Journal:  Histochemistry       Date:  1988

6.  Selective cytotoxicity of an oxygen-radical-generating enzyme conjugated to a monoclonal antibody.

Authors:  M G Battelli; A Abbondanza; P L Tazzari; A Dinota; S Rizzi; G Grassi; M Gobbi; F Stirpe
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

7.  An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.

Authors:  P L Tazzari; L Barbieri; M Gobbi; A Dinota; S Rizzi; A Bontadini; A Pession; S Tura; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  T lymphocyte killing by a xanthine-oxidase-containing immunotoxin.

Authors:  M G Battelli; A Abbondanza; P L Tazzari; A Bolognesi; R M Lemoli; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

9.  A comparison of anti-lymphocyte immunotoxins containing different ribosome-inactivating proteins and antibodies.

Authors:  A Bolognesi; P L Tazzari; C Tassi; G Gromo; M Gobbi; F Stirpe
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

10.  VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections.

Authors:  H Turley; M Jones; W Erber; K Mayne; M de Waele; K Gatter
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.